CytomX Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 6.72 M | $4.27 M | -8.12% | 7.71% |
| BVF INC/IL | 05/15/2025 | 5.23 M | $3.32 M | 0.00% | 6.00% |
| VANGUARD GROUP INC | 05/09/2025 | 5.12 M | $3.25 M | -0.87% | 5.87% |
| PROSIGHT MANAGEMENT, LP | 05/15/2025 | 3.93 M | $2.50 M | 0.64% | 4.51% |
| ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 3.23 M | $2.05 M | 3.09% | 3.71% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 2.83 M | $1.80 M | -12.26% | 3.24% |
| POINT72 ASSET MANAGEMENT, L.P. | 07/21/2025 | 2.65 M | $1.68 M | 0.00% | 3.04% |
| WOODLINE PARTNERS LP | 05/15/2025 | 1.66 M | $1.05 M | 100.00% | 1.90% |
| LAURION CAPITAL MANAGEMENT LP | 05/15/2025 | 1.29 M | $822.53 K | 3.63% | 1.48% |
| BLACKROCK, INC. | 05/02/2025 | 1.17 M | $741.59 K | -5.92% | 1.34% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 1.16 M | $734.99 K | -14.17% | 1.33% |
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 1.00 M | $635.80 K | 100.00% | 1.15% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 857.96 K | $545.63 K | 5.19% | 0.98% |
| GSA CAPITAL PARTNERS LLP | 05/08/2025 | 762.93 K | $485.00 K | 1,862.02% | 0.88% |
| UBS GROUP AG | 05/13/2025 | 746.79 K | $474.96 K | 46.84% | 0.86% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 711.45 K | $452.34 K | 18.61% | 0.82% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 686.21 K | $436.29 K | -55.65% | 0.79% |
| CONGRESS PARK CAPITAL LLC | 04/22/2025 | 673.69 K | $428.33 K | -30.16% | 0.77% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 589.33 K | $374.70 K | -57.32% | 0.68% |
| SEI INVESTMENTS CO | 05/14/2025 | 487.90 K | $310.21 K | 0.00% | 0.56% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 463.85 K | $294.55 K | 22,851.71% | 0.53% |
| FORMIDABLE ASSET MANAGEMENT, LLC | 05/05/2025 | 353.84 K | $224.97 K | -7.50% | 0.41% |
| TOROSO INVESTMENTS, LLC | 05/14/2025 | 353.84 K | $224.97 K | -7.50% | 0.41% |
| STATE STREET CORP | 05/15/2025 | 320.04 K | $203.48 K | 0.00% | 0.37% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 306.62 K | $194.95 K | -7.54% | 0.35% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 241.98 K | $153.85 K | 0.00% | 0.28% |
| NORTHERN TRUST CORP | 05/13/2025 | 150.63 K | $95.77 K | 0.00% | 0.17% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 116.48 K | $74.06 K | -63.69% | 0.13% |
| FMR LLC | 05/12/2025 | 108.31 K | $68.86 K | -64.69% | 0.12% |
| JPMORGAN CHASE & CO | 05/12/2025 | 105.29 K | $66.95 K | -87.03% | 0.12% |
| 05/06/2025 | 97.12 K | $61.75 K | 100.00% | 0.11% | |
| 05/14/2025 | 92.25 K | $88.61 K | 126.22% | 0.11% | |
| MARSHALL WACE, LLP | 05/15/2025 | 85.54 K | $54.75 K | 100.00% | 0.10% |
| PRUDENTIAL FINANCIAL INC | 05/13/2025 | 81.50 K | $51.82 K | 26.75% | 0.09% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2025 | 75.00 K | $47.69 K | 114.29% | 0.09% |
| GOLDMAN SACHS GROUP INC | 06/27/2025 | 61.72 K | $39.24 K | 100.00% | 0.07% |
| MORGAN STANLEY | 05/15/2025 | 60.58 K | $38.52 K | 358.93% | 0.07% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 54.81 K | $34.85 K | -0.54% | 0.06% |
| COMMONWEALTH EQUITY SERVICES, LLC | 05/09/2025 | 54.24 K | $34.00 K | 1.88% | 0.06% |
| 05/05/2025 | 51.00 K | $32.43 K | 104.00% | 0.06% | |
| CITADEL ADVISORS LLC | 05/15/2025 | 47.90 K | $30.46 K | 919.15% | 0.06% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 47.04 K | $29.91 K | -67.57% | 0.05% |
| RUSSELL INVESTMENTS GROUP, LTD. | 05/13/2025 | 44.58 K | $28.34 K | 30.90% | 0.05% |
| PRIVATE ADVISOR GROUP, LLC | 05/05/2025 | 44.00 K | $27.98 K | 0.00% | 0.05% |
| LPL FINANCIAL LLC | 05/07/2025 | 42.32 K | $26.90 K | 0.00% | 0.05% |
| SIMPLEX TRADING, LLC | 05/12/2025 | 33.85 K | $21.00 K | 100.00% | 0.04% |
| TRAPHAGEN INVESTMENT ADVISORS LLC | 04/17/2025 | 30.50 K | $19.39 K | 0.00% | 0.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 28.73 K | $18.27 K | -51.93% | 0.03% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 24.88 K | $15.82 K | 0.24% | 0.03% |
| JANE STREET GROUP, LLC | 05/19/2025 | 19.96 K | $12.69 K | -7.81% | 0.02% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CytomX Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 92 institutional investors and hedge funds held shares of CytomX Therapeutics, Inc.. The most heavily invested institutionals were:
TANG CAPITAL MANAGEMENT LLC: 6.72 M
BVF INC/IL: 5.23 M
VANGUARD GROUP INC: 5.12 M
Prosight Management, LP: 3.93 M
ACADIAN ASSET MANAGEMENT LLC: 3.23 M
MILLENNIUM MANAGEMENT LLC: 2.83 M
51.85% of CytomX Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 46.31 M shares in the last 24 months. This purchase volume represents approximately $112.54 M in transactions.